U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07434869) titled 'Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD' on Feb. 20.
Brief Summary: This study is for people who have had a lung transplant and developed a condition called chronic lung allograft dysfunction (CLAD), which is a type of chronic rejection. Doctors often treat CLAD with a procedure called extracorporeal photopheresis (ECP), but it can take up to six months to know if the treatment is working. The goal of the study is to find early signs (biomarkers) that show whether ECP is helping, so patients can get the right care sooner.
For participants in the study, small blood samples will be ...